Insider Transactions in Q1 2015 at Merck & Co., Inc. (MRK)
Insider Transaction List (Q1 2015)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 23
2015
|
Adele D Ambrose Sr.V-P & Chief Comuns Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,462
+12.75%
|
$142,796
$58.3 P/Share
|
|
Feb 23
2015
|
Kenneth C Frazier Executive Chair |
BUY
Grant, award, or other acquisition
|
Direct |
84,836
+16.22%
|
$4,920,488
$58.3 P/Share
|
|
Feb 23
2015
|
Willie A Deese Exe V-P & Pres. MMD |
BUY
Grant, award, or other acquisition
|
Direct |
8,762
+7.08%
|
$508,196
$58.3 P/Share
|
|
Feb 23
2015
|
Richard R. De Luca EVP&Pres, Merck Animal Heallth |
BUY
Grant, award, or other acquisition
|
Direct |
6,649
+41.43%
|
$385,642
$58.3 P/Share
|
|
Feb 23
2015
|
Julie L. Gerberding EVP, Chief Patient Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,736
+11.35%
|
$158,688
$58.3 P/Share
|
|
Feb 23
2015
|
Clark Golestani EVP & Chief Info Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,466
+12.81%
|
$85,028
$58.3 P/Share
|
|
Feb 23
2015
|
Weir Mirian M Graddick Exe V-P, HR |
BUY
Grant, award, or other acquisition
|
Direct |
11,190
+9.48%
|
$649,020
$58.3 P/Share
|
|
Feb 23
2015
|
Bruce N Kuhlik Exe V-P & Gen Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
14,282
+9.04%
|
$828,356
$58.3 P/Share
|
|
Feb 23
2015
|
Michael Rosenblatt Exec V-P & Chief Med Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,001
+14.1%
|
$290,058
$58.3 P/Share
|
|
Feb 23
2015
|
Adam H Schechter EVP & Pres-Global Human Health |
BUY
Grant, award, or other acquisition
|
Direct |
22,198
+50.0%
|
$1,287,484
$58.3 P/Share
|
|
Feb 18
2015
|
Kenneth C Frazier Executive Chair |
SELL
Open market or private sale
|
Direct |
5,164
-1.44%
|
$299,512
$58.67 P/Share
|
|
Feb 18
2015
|
Kenneth C Frazier Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
7,082
+1.94%
|
$219,542
$31.84 P/Share
|
|
Feb 11
2015
|
Willie A Deese Exe V-P & Pres. MMD |
SELL
Open market or private sale
|
Direct |
135,864
-56.12%
|
$7,880,112
$58.56 P/Share
|
|
Feb 11
2015
|
Willie A Deese Exe V-P & Pres. MMD |
BUY
Exercise of conversion of derivative security
|
Direct |
135,864
+18.78%
|
$5,434,560
$40.66 P/Share
|
|
Feb 09
2015
|
Wendell Peter C Director |
SELL
Open market or private sale
|
Direct |
5,000
-83.33%
|
$290,000
$58.76 P/Share
|
|
Feb 09
2015
|
Wendell Peter C Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+45.45%
|
$165,000
$33.83 P/Share
|
|
Jan 15
2015
|
Adam H Schechter EVP & Pres-Global Human Health |
SELL
Open market or private sale
|
Direct |
74,200
-100.0%
|
$4,600,400
$62.48 P/Share
|
|
Jan 15
2015
|
Adam H Schechter EVP & Pres-Global Human Health |
BUY
Exercise of conversion of derivative security
|
Direct |
74,200
+26.01%
|
$2,745,400
$37.92 P/Share
|
|
Jan 09
2015
|
Kenneth C Frazier Executive Chair |
SELL
Open market or private sale
|
Direct |
8,840
-2.45%
|
$548,080
$62.47 P/Share
|
|
Jan 09
2015
|
Kenneth C Frazier Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
12,874
+1.76%
|
$424,842
$33.47 P/Share
|